Aclaris Therapeutics (ACRS) Assets (2014 - 2026)
Aclaris Therapeutics' Assets came in at $179.69 million for Q2 2026, down 5.0% from $189.15 million a year earlier and down 9.6% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics' Assets was $160.46 million, down 27.2% from FY2024.
- Assets carries a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- Going back by year, Assets was $220.33 million in FY2024 (+11.6%), $197.41 million in FY2023 (-22.5%), $254.6 million in FY2022 (+1.3%) and $251.21 million in FY2021 (+254.9%).
- The five-year range for quarterly Assets is $160.46 million (Q4 2025) to $277.98 million (Q2 2022).
- Year-over-year, Assets increased in four of the last eight quarters, with an average decline of 1.2%.
- The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 266.5%), and the weakest in Q2 2024 (a decline of 31.6%).
- Business Quant data shows ACRS's Assets at $198.72 million (Q1 2026), $160.46 million (Q4 2025) and $175.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn | 179.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.69 Mn |
| Mar 31, 2026 | 198.72 Mn |
| Dec 31, 2025 | 160.46 Mn |
| Sep 30, 2025 | 175.53 Mn |
| Jun 30, 2025 | 189.15 Mn |
| Mar 31, 2025 | 198.09 Mn |
| Dec 31, 2024 | 220.33 Mn |
| Sep 30, 2024 | 182.39 Mn |
| Jun 30, 2024 | 161.07 Mn |
| Mar 31, 2024 | 174.07 Mn |
| Dec 31, 2023 | 197.41 Mn |
| Sep 30, 2023 | 218.35 Mn |
| Jun 30, 2023 | 235.65 Mn |
| Mar 31, 2023 | 229.71 Mn |
| Dec 31, 2022 | 254.60 Mn |
| Sep 30, 2022 | 267.63 Mn |
| Jun 30, 2022 | 277.98 Mn |
| Mar 31, 2022 | 226.53 Mn |
| Dec 31, 2021 | 251.21 Mn |
| Sep 30, 2021 | 263.49 Mn |
API Access
Aclaris Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();